IP Library Granted Patent US 10,266,818
Granted Patent B2
US 10,266,818 · App. 15/209,681 · Granted Apr 23, 2019

Treatment of gluten intolerance and related conditions

Inventors: David C. Schriemer (Chestermere, CA); Petr Man (Prague, CZ); Hynek Mrazek (Prague, CZ); Martial Rey (Calgary, CA)
Assignee: NEPETX, LLC
C12N9/63A23L29/06A23L33/10A23L33/105A61K38/488C12Y304/23012A23V2002/00A61K38/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,266,818
App. No.
15/209,681
Granted
Apr 23, 2019
Kind
B2
Abstract

Provided herein are compositions, foods comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof for modulating gluten intolerance and related conditions, such as celiac disease. Further provided herein are pharmaceutical compositions comprising nepenthesin or a derivative thereof and methods of using nepenthesin or a derivative thereof to treat bacterial infections of the gastrointestinal tract, such as C. difficile or H. pylori . Further provided herein are compositions comprising recombinant nepenthesin I or nepenthesin II, or homologous proteins, and methods for making the same.

Claims (11)

1. A composition comprising a recombinant nepenthesin and a transgenic organism wherein said transgenic organisms expresses said nepenthesin and comprises an expression vector, said expression vector comprising a nucleic acid sequence encoding said nepenthesin, wherein said nepenthesin encoded by said nucleic acid sequence comprises an amino acid sequence that is at least 95% identical to the amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NO: 7 without a plant signal sequence and having aspartic protease activity, wherein said organism is Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Lactobacillus , or Aspergilli.

2. The composition of claim 1 , wherein said recombinant nepenthesin comprises the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 5.

3. The composition of claim 1 , wherein said recombinant nepenthesin comprises the amino acid sequence of SEQ ID NO: 6.

4. The composition of claim 1 , wherein said recombinant nepenthesin comprises the amino acid sequence of SEQ ID NO: 7.

5. The composition of claim 1 , wherein said transgenic organism is Escherichia coli.

6. The composition of claim 1 , wherein said nucleic acid sequence encoding said nepenthesin has at least 95% sequence identity with a cDNA that encodes the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 5.

7. The composition of claim 1 , wherein said nucleic acid sequence encoding said nepenthesin has at least 95% sequence identity with a cDNA that encodes the amino acid sequence of SEQ ID NO: 6 or SEQ ID NO: 7.

8. An expression vector comprising a nucleic acid sequence encoding a nepenthesin, wherein said nepenthesin encoded by said nucleic acid sequence comprises an amino acid sequence that is at least 95% identical to the amino acid sequence selected from the group consisting of SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 5, SEQ ID NO: 6, and SEQ ID NO: 7 without a plant signal sequence and having aspartic protease activity.

9. The expression vector of claim 8 , wherein said nepenthesin comprises the amino acid sequence of SEQ ID NO: 3, SEQ ID NO: 4, or SEQ ID NO: 5.

10. The expression vector of claim 8 , wherein said nepenthesin comprises the amino acid sequence of SEQ ID NO: 6.

11. The expression vector of claim 8 , wherein said nepenthesin comprises the amino acid sequence of SEQ ID NO: 7.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jan 8, 2025
From: INNOVATUS LIFE SCIENCES LENDING FUND I, LP
To: CODEXIS, INC.
Reel/Frame 069789/0740 →
SECURITY INTEREST Recorded Feb 15, 2024
From: CODEXIS, INC.
To: INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT
Reel/Frame 066600/0650 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2020
From: NEPETX, LLC
To: CODEXIS, INC.
Reel/Frame 052804/0249 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: SCHRIEMER, DAVID C.; REY, MARTIAL
To: NEPETX, LLC
Reel/Frame 043524/0986 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: MAN, PETR; MRAZEK, HYNEK
To: NEPETX, LLC
Reel/Frame 043525/0071 →
Continuity (5)
Continuation 14620066 · Feb 11, 2015
Division 13843369 · Mar 15, 2013
Provisional Application 61797040 · Nov 27, 2012
Provisional Application 61729210 · Nov 21, 2012
Related Publication 20170067040A1 · Mar 9, 2017